Lena Kanter

1.7k total citations
39 papers, 1.3k citations indexed

About

Lena Kanter is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lena Kanter has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Lena Kanter's work include Acute Myeloid Leukemia Research (5 papers), Cutaneous Melanoma Detection and Management (4 papers) and Melanoma and MAPK Pathways (3 papers). Lena Kanter is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Cutaneous Melanoma Detection and Management (4 papers) and Melanoma and MAPK Pathways (3 papers). Lena Kanter collaborates with scholars based in Sweden, United States and Germany. Lena Kanter's co-authors include Anton Platz, Ulrik Ringborg, Johan Hansson, Katarina Omholt, Rolf Lewensohn, Kristina Viktorsson, Luigi De Petris, Åsa Holgersson, Janne Lehtiö and Bo Nilsson and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Lena Kanter

39 papers receiving 1.3k citations

Peers

Countries citing papers authored by Lena Kanter

Since Specialization

Citations

This map shows the geographic impact of Lena Kanter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lena Kanter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lena Kanter more than expected).

Fields of papers citing papers by Lena Kanter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lena Kanter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lena Kanter. The network helps show where Lena Kanter may publish in the future.

Co-authorship network of co-authors of Lena Kanter

This figure shows the co-authorship network connecting the top 25 collaborators of Lena Kanter. A scholar is included among the top collaborators of Lena Kanter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lena Kanter. Lena Kanter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Caspase-2 is a mediator of apoptotic signaling in response to gemtuzumab ozogamicin in acute myeloid leukemia 2022 ·Cell Death Discovery ·Petra Hååg, Magnus Olsson, (unknown), Marita Lagergren Lindberg, Bo Stenerlöw, Dali Zong, Lena Kanter, Rolf Lewensohn, Kristina Viktorsson, Boris Zhivotovsky, Leif Stenke	2
2	Multiplex immune protein profiling of fine‐needle aspirates from patients with non‐small‐cell lung cancer reveals signatures associated with PD‐L1 expression and tumor stage 2021 ·Molecular Oncology ·Bo Franzén, Kristina Viktorsson, (unknown), (unknown), Vitali Grozman, (unknown), Petra Hååg, Vitaliy O. Kaminskyy, Per Hydbring, Lena Kanter, Sven Nyrén, Simon Ekman, Luigi De Petris, Rolf Lewensohn	10
3	The prognostic implications of Notch1, Hes1, Ascl1, and DLL3 protein expression in SCLC patients receiving platinum-based chemotherapy 2020 ·PLoS ONE ·(unknown), Lena Kanter, Rolf Lewensohn, Cristian Ortiz‐Villalón, Kristina Viktorsson, Luigi De Petris	23
4	Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression 2018 ·Lung Cancer ·Per Hydbring, Luigi De Petris, Yanming Zhang, Eva Brandén, Hirsh Koyi, Metka Novak, Lena Kanter, Petra Hååg, James Hurley, Vasisht Tadigotla, Baoli Zhu, Johan Skog, Kristina Viktorsson, Simon Ekman, Rolf Lewensohn	55
5	Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells 2017 ·Cell Death and Disease ·Alireza Azimi, Rainer Tuominen, Fernanda Costa Svedman, Stefano Caramuta, Maria Pernemalm, Marianne Frostvik Stolt, Lena Kanter, Pedram Kharaziha, Janne Lehtiö, Carolina Johansson, Veronica Höiom, Johan Hansson, Suzanne Egyházi Brage	30
6	Melphalan‐flufenamide is cytotoxic and potentiates treatment with chemotherapy and the Src inhibitor dasatinib in urothelial carcinoma 2016 ·Molecular Oncology ·Kristina Viktorsson, (unknown), (unknown), Petra Hååg, (unknown), (unknown), (unknown), (unknown), Jack Spira, Lena Kanter, Rolf Lewensohn, Anders Ullén	11
7	Vascular endothelial growth factor receptor 2, but not S100A4 or S100A6, correlates with prolonged survival in advanced urothelial carcinoma 2014 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Kristina Viktorsson, Lena Kanter, Amir Sherif, (unknown), Robert Rosenblatt, Rolf Lewensohn, Anders Ullén	9
8	Expression of the p53 Target Wig-1 Is Associated with HPV Status and Patient Survival in Cervical Carcinoma 2014 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), Lena Kanter, Mikael Lerner, Biying Zheng, Svetlana Bajalica‐Lagercrantz, Dan Grandér, (unknown), Klas G. Wiman, Catharina Larsson, Sonia Andersson	2
9	Clinical activity of sorafenib in a previously treated advanced urothelial cancer patient 2013 ·Anti-Cancer Drugs ·(unknown), Kristina Viktorsson, Amir Sherif, Lena Kanter, Per Grybäck, Rolf Lewensohn, Per Sandström, Sten Nilsson, (unknown)	1
10	Neuroblastoma cells injected into experimental mature teratoma reveal a tropism for embryonic loose mesenchyme 2013 ·International Journal of Oncology ·(unknown), Jessica Cedervall, Isabell Hultman, (unknown), Naira V. Margaryan, Agnes Rasmuson, John Inge Johnsen, Baldur Sveinbjørnsson, Tina Dalianis, Lena Kanter, Abiel Orrego, Luigi Strizzi, Mary J.C. Hendrix, Bengt Sandstedt, Per Kogner, (unknown)	11
11	Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma 2012 ·International Journal of Oncology ·(unknown), David Lindquist, Lena Kanter, (unknown), Roger Henriksson, Håkan Hedman, Sonia Andersson	33
12	Use of narrow‐range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion 2009 ·PROTEOMICS ·Maria Pernemalm, Luigi De Petris, Hanna Eriksson, Eva Brandén, Hirsh Koyi, Lena Kanter, Rolf Lewensohn, Janne Lehtiö	44
13	Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer 2008 ·Lung Cancer ·Luigi De Petris, Lukas M. Orre, Lena Kanter, Maria Pernemalm, Hirsh Koyi, Rolf Lewensohn, Janne Lehtiö	51
14	Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell linesin vitro 2007 ·Growth Factors ·(unknown), (unknown), (unknown), Raluca A. Budiu, (unknown), Maria Starborg, (unknown), Lena Kanter, Rolf Lewensohn, Anica Dricu	21
15	Modulation of response to radiation of human lung cancer cells following insulin-like growth factor 1 receptor inactivation 2004 ·Cancer Letters ·(unknown), (unknown), Juan Castro, Jessica Ekedahl, Lena Kanter, Rolf Lewensohn, Anica Dricu	36
16	Frequency of UV-Inducible NRAS Mutations in Melanomas of Patients With Germline CDKN2A Mutations 2003 ·JNCI Journal of the National Cancer Institute ·Malihe Eskandarpour, Jamileh Hashemi, Lena Kanter, Ulrik Ringborg, Anton Platz, Johan Hansson	52
17	Expression of the insulin-like growth factor 1 receptor (IGF-1R) in breast cancer cells: evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-1 pathway 1999 ·Glycobiology ·Anica Dricu, Lena Kanter, (unknown), Gunnar Nilsson, Magnus Hjertman, Johan Wejde, Olle Larsson	33
18	Reverse Transcriptase Polymerase Chain Reaction on Fine Needle Aspirates for Rapid Detection of Translocations in Synovial Sarcoma 1998 ·Acta Cytologica ·Gunnar Nilsson, Min Wang, Johan Wejde, Lena Kanter, Jonas Karlén, Edneia Tani, Andris Kreicbergs, Olle Larsson	18
19	Paneth Cell‐rich Flat Adenoma of the Rectum: Report of a Case 1996 ·Japanese Journal of Cancer Research ·Carlos Rubio-Terrés, Lena Kanter, Jan Björk, Bertil Poppen, Lynn Bry	14
20	Utility of a proliferation marker in distinguishing between benign naevocellular naevi and naevocellular naevus-like lesions with malignant properties 1995 ·Melanoma Research ·Lena Kanter, Harald Blegen, Johan Wejde, (unknown), Olle Larsson	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact